- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Leverage Leaders
Swedish Pharmaceuticals & Biotech Leverage Leaders
Results
3
0 new
3 companies
Camurus
Market Cap: SEK 36.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 611.00
7D
-1.7%
1Y
3.6%
BioArctic
Market Cap: SEK 27.4b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 309.60
7D
-1.2%
1Y
46.0%
Swedish Orphan Biovitrum
Market Cap: SEK 115.0b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 333.80
7D
0.1%
1Y
4.7%